ArticleOPEN ACCESS

Managing dopamine agonist withdrawal syndrome in Parkinson's disease

Progress in Neurology and Psychiatry
DOI: 10.1002/pnp.203
3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dopamine agonist withdrawal syndrome (DAWS) has recently been named in the Archives of Neurology. It describes a cluster of symptoms occurring in Parkinson's disease patients with impulse control disorders on tapering down or withdrawal of their dopamine agonist. Drs Lindahl and MacMahon discuss the risk factors for the development of DAWS and some approaches to its management. © 2011 Wiley Interface Ltd.

Cite

CITATION STYLE

APA

Lindahl, A. J., & Macmahon, D. G. (2011, July). Managing dopamine agonist withdrawal syndrome in Parkinson’s disease. Progress in Neurology and Psychiatry. https://doi.org/10.1002/pnp.203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free